How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical Septal Occluder Device Market
- By Device Type: Atrial Septal Defect (ASD) Occluders, Ventricular Septal Defect (VSD) Occluders, Patent Foramen Ovale (PFO) Occluders, Patent Ductus Arteriosus (PDA) Occluders, Multi-Fenestrated Septal Occluders
- By Material: Nitinol Mesh, Polyester Fabric, Polytetrafluoroethylene (PTFE), Stainless Steel, Cobalt-Chromium Alloy
- By End User: Hospitals, Cardiac Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers
- By Procedure Type: Percutaneous Transcatheter Occlusion, Surgical Septal Occlusion
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Atrial Septal Defect (ASD) Occluders leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 12 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 265 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.163 →
- 11 Company Profiles 12 players: SWOT & benchmarking p.171 →
Full report · locked preview
Everything inside the Medical Septal Occluder Device Market report
A complete, evidence-based study - 11 chapters and 111 sections covering market size, segmentation across 4 axes, regional analysis and 12 company profiles, forecast to 2033.
Segmentation covered
Device Type 5
Material 5
End User 4
Procedure Type 2
Companies profiled
Abbott Laboratories
Medtronic plc
W.L. Gore & Associates Inc.
Lifetech Scientific Corporation
Occlutech GmbH
Cardinal Health Inc.
Shanghai Shape Memory Alloy Co. Ltd.
LivaNova PLC
MicroPort Scientific Corporation
Sino Medical Sciences Technology Inc.
Lepu Medical Technology (Beijing) Co. Ltd.
Vascular Innovations Co. Ltd.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
12 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →W.L. Gore & Associates Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Lifetech Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Occlutech GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Cardinal Health Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Shanghai Shape Memory Alloy Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →LivaNova PLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →MicroPort Scientific Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Sino Medical Sciences Technology Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Lepu Medical Technology (Beijing) Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Vascular Innovations Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,564M by 2033 · 10.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Atrial Septal Defect (ASD) Occluders30.3
- Ventricular Septal Defect (VSD) Occluders19.6
- Patent Foramen Ovale (PFO) Occluders13.6
- Patent Ductus Arteriosus (PDA) Occluders12.4
- Multi-Fenestrated Septal Occluders24.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$379.5M → $935.2M · 11.9%
Europe$264.5M → $632.0M · 11.5%
Asia Pacific$241.5M → $518.4M · 10.0%
Latin America$149.5M → $302.5M · 9.2%
Middle East and Africa$115.0M → $259.7M · 10.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.502026
10.512027
10.512028
10.522029
10.542030
10.562031
10.572032
10.582033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Abbott Laboratories11.0
- Medtronic plc24.5
- W.L. Gore & Associates Inc.6.5
- Lifetech Scientific Corporation11.9
- Occlutech GmbH10.6
- Cardinal Health Inc.7.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type18.6%
Material16.6%
End User44.1%
Procedure Type20.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.3
- Europe23.9
- Asia Pacific19.6
- Latin America11.4
- Middle East and Africa9.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 75 | 81 | 86 | 91 | 92 | 76 | 84 |
| Medtronic plc | 80 | 86 | 75 | 85 | 81 | 86 | 82 |
| W.L. Gore & Associates Inc. | 68 | 74 | 80 | 64 | 70 | 67 | 71 |
| Lifetech Scientific Corporation | 64 | 81 | 60 | 70 | 76 | 72 | 71 |
| Occlutech GmbH | 63 | 66 | 72 | 60 | 65 | 70 | 66 |
| Cardinal Health Inc. | 53 | 59 | 59 | 70 | 50 | 56 | 58 |
| Shanghai Shape Memory Alloy Co. Ltd. | 63 | 43 | 44 | 46 | 50 | 62 | 51 |
| LivaNova PLC | 45 | 50 | 59 | 56 | 36 | 45 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Abbott Laboratories
- Medtronic plc
- W.L. Gore & Associates Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Abbott Laboratories | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Medtronic plc | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| W.L. Gore & Associates Inc. | ◐ | ✓ | ◐ | − | ◐ | − |
| Lifetech Scientific Corporation | − | ◐ | ◐ | ◐ | ✓ | ◐ |
| Occlutech GmbH | ◐ | ✓ | ◐ | ◐ | − | ◐ |
| Cardinal Health Inc. | − | − | ◐ | ◐ | − | ◐ |
| Shanghai Shape Memory Alloy Co. Ltd. | ◐ | − | − | ◐ | − | ◐ |
| LivaNova PLC | ◐ | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Abbott Laboratories84
2Medtronic plc82
3W.L. Gore & Associates Inc.71
4Lifetech Scientific Corporation71
5Occlutech GmbH66
6Cardinal Health Inc.58
7Shanghai Shape Memory Alloy Co. Ltd.51
8LivaNova PLC49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Abbott LaboratoriesMedtronic plc
Challenger2
Strong scale, closing on the leaders.
W.L. Gore & Associates Inc.Lifetech Scientific Corporation
Contender2
Focused players with pockets of strength.
Occlutech GmbHCardinal Health Inc.
Niche2
Specialists in a single segment or region.
Shanghai Shape Memory Alloy Co. Ltd.LivaNova PLC
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across Medical Septal Occluder Device Market — a $83M beachhead inside a $1.26B market.
Beachhead (SOM)$83Mobtainable near-term
Serviceable (SAM)$467Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Atrial Septal Defect (ASD) Occluders
Best fit — highest urgency & budget in Device Type.
Economic buyer78 fit
Ventricular Septal Defect (VSD) Occluders
Strong fit — clear ROI and a fast path to value.
End user67 fit
Patent Foramen Ovale (PFO) Occluders
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical Septal Occluder Device Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified26%
Evaluation12%
Closed-won5%
$20.1KCAC
$95KLTV
4.7:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical Septal Occluder Device Market is a durable-growth opportunity — $8.27B by 2033, compounding at 9.6%.
TAM · 2025$3.98Btoday
TAM · 2033$8.27Bforecast
CAGR9.6%2027–2033
Cumulative$53.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.27BTotal addressable market
SAM$3.25BServiceable available market
SOM$664MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.6% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
12+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.27BLarge & growingTAM by 2033 at 9.6% CAGR
$3.25BServiceable nowreachable with today’s model
$664MBeachhead winobtainable near-term share
12+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.45BBear6.2% CAGR
$8.27BBase9.6% CAGR
$10.6BBull12.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical Septal Occluder Device Market — a $5.90B market by 2033. Plan: grow share from 10.9% to 17.4%.
Market size · 2033$5.90Btotal addressable
Market CAGR8.8%2027–2033
Target share17.4%from 10.9% today
Revenue ambition$1.03Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.9% | 17.4% | Ahead |
| Revenue | $579M | $1.03B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 31.2% | 40.0% | Ahead |
| Customer retention | 86.6% | 93.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $129M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical Septal Occluder Device Market conversation — a $8.42B market you can size, segment and defend in minutes.
Market size · 2033$8.42Btotal opportunity
Growth5.4%CAGR to 2033
Addressable buyers1,052+accounts in scope
Typical ROI5.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.2×return on cost, year one
< 3 mopayback period
$83K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
12+players profiled in this market
Coverage includes
Abbott LaboratoriesMedtronic plcW.L. Gore & Associates Inc.Lifetech Scientific CorporationOcclutech GmbHCardinal Health Inc.Shanghai Shape Memory Alloy Co. Ltd.LivaNova PLC+4 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical Septal Occluder Device Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical Septal Occluder Device Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Medical Sensor Patches Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportMedical Sensor for ICU Monitoring Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportMedical Sensor Faucet Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportMedical Self Service Platform Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportMedical Self-Service Kiosks Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportMedical Self-seal Sterilization Pouches Market
Market size, share, segmentation and regional forecast.
$534M market · 2025 base year
View reportMedical Self-Adhesive Electrodes Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportMedical Security Seals Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportMedical Security Information System Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportMedical Second Opinion Services Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportMedical Second Opinion Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportMedical Secondary Packaging Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.